Study of helicobacter pylori negative, non-steroidal anti-inflammatory drug-negative peptic ulcers in a tertiary care center

 

 

REFERENCES

1. Narayanan, M.; Reddy, K.M.; Marsicano, E. Peptic ulcer disease and Helicobacter pylori infection. Mo. Med. 2018, 115, 219–224. [PubMed]
2. Lanas, A.; Chan, F.K.L. Peptic ulcer disease. Lancet 2017, 390, 613–624.
3. Musumba C, Jorgensen A, Sutton L, Van Eker D, Moorcroft J, Hopkins M, Pritchard DM, Pirmohamed M. The relative contribution of NSAIDs and Helicobacter pylori to the aetiology of endoscopically-diagnosed peptic ulcer disease: observations from a tertiary referral hospital in the UK between 2005 and 2010. Aliment Pharmacol Ther 2012; 36: 48-56
4. Huang, J.Q.; Sridhar, S.; Hunt, R.H. Role of helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: A meta-analysis. Lancet 2002, 359, 14–22.
5. Hung LC, Ching JY, Sung JJ, To KF, Hui AJ, Wong VW, Leong RW, Chan HL, Wu JC, Leung WK, Lee YT, Chung SC, Chan FK. Long-term outcome of Helicobacter pylori-negative idiopathic bleeding ulcers: a prospective cohort study. Gastroenterology 2005; 128: 1845-1850
6. Søreide, K.; Thorsen, K.; Harrison, E.M.; Bingener, J.; Møller, M.H.; Ohene-Yeboah, M.; Søreide, J.A. Perforated peptic ulcer. Lancet 2015, 386, 1288–1298.
7. Bhatia V, Tandon RK. Stress and the gastrointestinal tract. J Gastroenterol Hepatol. 2005;20(3):332-9.
8. Fink G. Stress Controversies: Post-Traumatic Stress Disorder, Hippocampal Volume, Gastroduodenal Ulceration. J Neuroendocrinol. 2011;23(2):107-17.
9. National Digestive Diseases Information Clearinghouse. Available at http://digestive.niddk. nih.gov/dddiseases/pubs/hpy. Accessed 19 August 2018.
10. Rayan Harshman M, Aldoori W. How Diet and Lifestyle Affect Duodenal Ulcers. Review of The Evidence. CandFamily Physi Med Medecin De Famille Canadien. 2004;50:727-32.
11. Chan FK. Proton-pump inhibitors in peptic ulcer disease. Lancet 2008;372:1198–1200.
12. Lee YC, Chen TH, Chiu HM, et al. The benefit of mass eradication of Helicobacter pylori infection: a com¬munity-based study of gastric cancer prevention. Gut 2013;62:676-682.
13. IARC Helicobacter pylori Working Group. Helicobacter pylori eradication as a strategy for gastric cancer pre¬vention (IARC Working Group Reports, No. 8) Available from: http://www.iarc. fr/en/publications/pdfs-online/wrk/wrk8/index.php.
14. Malfertheiner P, Chan FK, McColl KE. Peptic ulcer disease. Lancet 2009; 374: 1449-1461
15. Gisbert JP, Abraira V. Accuracy of Helicobacter pylori diagnostic tests in patients with bleeding peptic ulcer: a systematic review and meta-analysis. Am J Gastroenterol 2006;101:848-863.
16. Xia HH, Kalantar JS, Mitchell HM, Talley NJ. Can helicobacter pylori serology still be applied as a surrogate marker to identify peptic ulcer disease in dyspepsia? Aliment Pharmacol Ther 2000;14:615-24.
17. Goenka MK, Majumder S, Sethy PK, Chakraborty M. Helicobacter pylori negative, non-steroidal anti-inflammatory drugnegative peptic ulcers in India. Indian J Gastroenterol 2011;30:33-7.
18. Sbrozzi-Vanni A, Zullo A, Di Giulio E, Hassan C, Corleto VD, Lahner E, et al. Low prevalence of idiopathic peptic ulcer disease: an Italian endoscopic survey. Dig Liver Dis 2010;42:773-6.
19. Ootani H, Iwakiri R, Shimoda R, Nakahara S, Amemori S, Fujise T, et al. Role of Helicobacter pylori infection and non-steroidal anti inflammatory drug use in bleeding peptic ulcers in Japan. J Gastroenterol 2006;41:41-6.
20. Wong GL, Wong VW, Chan Y, et al. High incidence of mortality and recurrent bleeding in patients with Helicobacter pylori-negative idiopathic bleeding ulcers. Gastroenterology 2009;137:525–531.
21. Gillen D, Wirz AA, Ardill JE, et al. Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status. Gastroenterology 1999;116:239– 247.